26 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
results to the plaintiff(s) in any such action.
The deposit agreement governing our ADSs provides that holders and beneficial owners of ADSs irrevocably … results that could be less favorable to the plaintiff(s) in any such action, depending on, among other things, the nature of the claims, the judge
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
agrees to be joined as a party plaintiff where necessary under Applicable Law for such initiating Party to initiate and maintain such claim, litigation
F-3/A
b2xfxes8y3l6fxnt7db
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
j2ondrjd 5cpa95
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
ydk80u5
5 Aug 21
Shelf registration (foreign)
4:33pm
F-3
EX-1.2
ucapwqpd5uvndk
5 Aug 21
Shelf registration (foreign)
4:33pm
424B5
21j9u17872ez9avs
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
s38pyn6qvn8tne0q
9 Feb 21
Prospectus supplement for primary offering
5:24pm
424B5
l31idxuilxq1kkhidj7s
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
c7iv87hcd7u70ob82nti
6 Oct 20
Shelf registration (foreign)
4:25pm
6-K
EX-10.1
ej4wnemj8rn
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
F-1/A
hfxjil fe
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
gsk0qekknf xasz
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
EX-10.2
oe4wv1nv
19 Feb 20
Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor
9:32am